Keyphrases
Confidence Interval
100%
Age-related Macular Degeneration
100%
Bevacizumab
100%
Vascular Events
100%
Myocardial Infarction
50%
Intraocular Injection
50%
Hypertension
25%
Bleeding
25%
Increased Blood Pressure
25%
Cerebrovascular Accident
25%
Retina
25%
St. Louis
25%
Neovascular Age-related Macular Degeneration (nAMD)
25%
Intravitreal Ranibizumab
25%
Non-lethal
25%
Patient 2.0
25%
Nursing and Health Professions
Bevacizumab
100%
Age Related Macular Degeneration
100%
Confidence Interval
80%
Heart Infarction
40%
Intraocular Drug Administration
40%
Bleeding
20%
Thromboembolism
20%
Elevated Blood Pressure
20%
Cerebrovascular Accident
20%
Wet Macular Degeneration
20%
Pharmacology, Toxicology and Pharmaceutical Science
Age Related Macular Degeneration
100%
Bevacizumab
100%
Heart Infarction
40%
Bleeding
20%
Elevated Blood Pressure
20%
Thromboembolism
20%
Wet Macular Degeneration
20%
Cerebrovascular Accident
20%